SCHEMBL24752397

SCHEMBL24752397

CC1(C)c2ccccc2-c2ccc(N(c3ccccc3-c3ccccc3)c3ccccc3-c3cccc4c3-c3ccccc3C4(c3ccccc3)c3ccccc3)cc21

nearest known ligand 0.30

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ OPRK1 P41145 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26053602 0.96 KDM4E (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL18468741 0.95 KDM4E (0.31) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL25125239 0.95 PDK2 (0.32) PDK2
SCHEMBL26027761 0.94 KDM4E (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL20345925 0.94 KDM4E (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16802070 0.94 KDM4E (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL29548869 0.94 PDK2 (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL16801963 0.94 PDK2 (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL29899202 0.94 PDK2 (0.30) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL21102283 0.94 PDK2 (0.31) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354625-A1 PHOTOELECTRIC CONVERSION DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-11-02 — — US disclosed
US-11711973-B2 Organic electronic device DUK SAN NEOLUX CO., LTD. (KR) 2023-07-25 — — US disclosed
US-11711973-B2 Organic electronic device DUK SAN NEOLUX CO., LTD. (KR) 2023-07-25 — — US disclosed
US-20230132153-A1 Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20230132153-A1 Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-04-27 — — US disclosed
US-20230111469-A1 Organic Electronic Device DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 — — US disclosed
US-20220393123-A1 LIGHT-RECEIVING DEVICE, LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230132153-A1 Organic Compound CCNA1, DRD1, CYP1A1 KDM4E 2541/4885MEN1 506/4885LMNA 3600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback